Qube Research & Technologies (QRT)
STOK icon

Qube Research & Technologies (QRT)’s Stoke Therapeutics STOK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,432
Closed -$263K – 3799
2024
Q3 		$263K Sell
21,432
-76,366
-78% -$1.08M ﹤0.01% 2476
2024
Q2 		$1.32M Buy
+97,798
New +$1.32M ﹤0.01% 1784
2024
Q1 		– Sell
-35
Closed -$184 – 4852
2023
Q4 		$184 Buy
+35
New +$150 ﹤0.01% 3981
2022
Q3 		– Sell
-27,158
Closed -$359K – 3007
2022
Q2 		$359K Buy
27,158
+2,128
+9% +$32.3K ﹤0.01% 1531
2022
Q1 		$527K Buy
+25,030
New +$501K ﹤0.01% 1509
2021
Q4 		– Sell
-9,992
Closed -$254K – 2953
2021
Q3 		$254K Sell
9,992
-1,584
-14% -$44.2K ﹤0.01% 1549
2021
Q2 		$390K Sell
11,576
-792
-6% -$28K ﹤0.01% 1414
2021
Q1 		$480K Buy
+12,368
New +$704K 0.01% 1205
2020
Q3 		– Sell
-12,970
Closed -$309K – 2088
2020
Q2 		$309K Buy
+12,970
New +$308K ﹤0.01% 1287

Other funds holding STOK

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Qube Research & Technologies (QRT)'s STOK Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Stoke Therapeutics (STOK) in Q4 2024, closing a stake of 21,432 shares — an estimated $263K sold.

Qube Research & Technologies (QRT) first reported a position in STOK in Q2 2020 and held it in 9 quarters. The position peaked at $1.32M in Q2 2024. 130 funds tracked by Wall St. Rank hold STOK as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Stoke Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 21,432 Stoke Therapeutics shares in Q4 2024, an estimated $263K.
  • Qube Research & Technologies (QRT) first reported a position in Stoke Therapeutics in Q2 2020 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Stoke Therapeutics position peaked at $1.32M in Q2 2024.
  • 130 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.